The earnings season is coming to a close, and Goldman Sachs says that companies’ performance this time is one of the best ever.
Best Stocks: Rounding out our biotech exposure with a big winner, one we missed and another we’re still early on
Josh Brown and Sean Russo break down three biotech names in the Best Stocks list.
UBS upgrades CVS to buy rating, sees further recovery ahead
UBS analyst Kevin Caliendo’s revised price target implies 15% upside ahead for shares of the health care benefit and pharmacy chain.
Morgan Stanley says nuclear power is gaining momentum, recommends these stocks
The investment bank sees the U.S. adding 150 gigawatts of nuclear power by the middle of century.
Using options to trade Target earnings due out later this week
Options trader Michael Khouw breaks down an options trade on Target ahead of earnings.
Bitcoin sinks to $115,000 after hitting its newest record, as macro concerns spark liquidation wave
The crypto market tumbled to begin the week as heightened macro concerns triggered more than $500 million in long liquidations.
Here are Monday’s biggest analyst calls: Nvidia, Apple, Tesla, Duolingo, Netflix, Target, CVS, Sunrun, Live Nation & more
Here are the biggest calls on Wall Street on Monday.
Deutsche Bank initiates this ‘hidden gem’ education stock at a buy rating
McGraw Hill is set up to be a strong artificial intelligence beneficiary, Deutsche Bank said.
Morgan Stanley maintains bullish stance on Nvidia heading into earnings, raises price target
Nvidia reports its second-quarter earnings next Wednesday, Aug 27.
RBC Capital Markets upgrades this solar stock to outperform following tax credit clarification
RBC Capital Markets believes that Sunrun’s cash generation in 2026 could climb to $550 million from $308 million in 2025.